The intracranial hemorrhage devices market size has grown strongly in recent years. It will grow from $1.79 billion in 2025 to $1.88 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing incidence of traumatic brain injuries, rising prevalence of stroke cases, expansion of neurocritical care units, growth in emergency medical services, availability of advanced diagnostic devices.
The intracranial hemorrhage devices market size is expected to see steady growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing investments in neurotechnology, rising demand for real-time brain monitoring, expansion of minimally invasive neurosurgery, growing adoption of AI-assisted imaging analysis, increasing focus on early intervention protocols. Major trends in the forecast period include increasing use of advanced neuroimaging devices, rising adoption of minimally invasive treatment solutions, growing integration of intracranial pressure monitoring, expansion of emergency stroke and trauma care, enhanced focus on rapid diagnosis and intervention.
The rising cases of brain disorders are expected to propel the growth of the intracranial hemorrhage devices market going forward. Brain disorders refer to a wide range of conditions that affect the structure, function, or chemistry of the brain, leading to disruptions in normal brain processes. The cases of brain disorders are increasing due to factors such as improved diagnostics, aging populations, lifestyle changes, and greater awareness, along with rising stress. Intracranial hemorrhage devices are used to detect, monitor, and treat brain disorders involving bleeding by identifying hemorrhages, managing pressure, and removing blood clots to prevent further brain damage. For instance, in October 2025, according to the World Health Organization, a Switzerland-based Intergovernmental organization reported that The WHO warns that fewer than one in three countries have a national policy to tackle neurological disorders, which cause over 11 million deaths annually. Additionally, its new report shows these conditions affect over 3 billion people,more than 40% of the global population. Therefore, the rising cases of brain disorders drive the growth of the intracranial hemorrhage devices market.
Leading companies in the intracranial hemorrhage devices market are focused on creating innovative products, such as advanced neuro access devices, to improve the precision and efficiency of diagnosing and treating brain injuries. These devices are specialized tools and technologies designed to provide accurate access to the brain or nervous system for diagnostic, surgical, or therapeutic purposes. For instance, in June 2024, Penumbra Inc., a medical device company based in the US, launched its advanced neuro access devices, BMX81 and BMX96, in Europe. These devices, designed for managing ischemic and hemorrhagic strokes, use advanced laser-cut stainless steel hypotube technology to enhance stability and trackability while allowing for larger inner diameters. This launch underscores Penumbra's dedication to improving stroke care in Europe.
In September 2024, Stryker Corporation, a US-based medical company, acquired NICO Corporation for an undisclosed amount. The acquisition aims to strengthen Stryker’s neurotechnology capabilities in tumor and stroke care, as well as expand its portfolio of solutions for tumor resection and the treatment of intracerebral hemorrhage. NICO Corporation, a US-based medical equipment manufacturer, specializes in devices for treating intracranial hemorrhage (ICH).
Major companies operating in the intracranial hemorrhage devices market are Johnson & Johnson Services Inc., Medtronic Inc., Siemens Healthcare GmbH, Stryker Corporation, General Electric Company, Terumo Corporation, Canon Medical Systems Corporation, Penumbra Inc., MicroPort Scientific Corporation, Aidoc Medical Ltd., Viz.ai Inc., Phenox GmbH, RAPID AI Inc., Acandis GmbH, Kaneka Medix Corporation, Hyperfine Inc., ClearMind Biomedical Inc., InfraScan Inc., Schindler Endoskopie Technologie GmbH, Sense Neuro Diagnostics Inc., MaxQ AI Inc., Invamed Inc.
North America was the largest region in the intracranial hemorrhage devices market in 2025. The regions covered in the intracranial hemorrhage devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intracranial hemorrhage devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intracranial hemorrhage devices market by increasing costs of imported imaging systems, monitoring sensors, surgical instruments, and electronic components used in diagnostic and treatment devices. Hospitals in North America and Europe are most affected due to reliance on advanced imported imaging and monitoring equipment, while Asia-Pacific faces higher capital expenditure for device procurement. These tariffs are raising treatment costs and delaying equipment upgrades. However, they are also encouraging domestic manufacturing, localized assembly, and investment in regional neurodevice development capabilities.
The intracranial hemorrhage devices market research report is one of a series of new reports that provides intracranial hemorrhage devices market statistics, including intracranial hemorrhage devices industry global market size, regional shares, competitors with a intracranial hemorrhage devices market share, detailed intracranial hemorrhage devices market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial hemorrhage devices industry. This intracranial hemorrhage devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intracranial hemorrhage devices are medical tools designed for diagnosing, managing, and treating intracranial hemorrhages (ICH), which are bleeding events within the skull. These devices are essential for addressing conditions such as subdural hematoma, epidural hematoma, subarachnoid hemorrhage, and intracerebral hemorrhage.
The primary product categories for intracranial hemorrhage devices include diagnostic and treatment devices. Intracranial hemorrhage diagnosis refers to the process of detecting bleeding within the skull, utilizing both invasive and non-invasive devices. These devices serve various end users, such as hospitals, ambulatory surgical centers, and other healthcare facilities.
The intracranial hemorrhage devices market consists of sales of embolization devices, computed tomography scanners, balloon occlusion devices, and neuro-thrombectomy devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The intracranial hemorrhage devices market size is expected to see steady growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing investments in neurotechnology, rising demand for real-time brain monitoring, expansion of minimally invasive neurosurgery, growing adoption of AI-assisted imaging analysis, increasing focus on early intervention protocols. Major trends in the forecast period include increasing use of advanced neuroimaging devices, rising adoption of minimally invasive treatment solutions, growing integration of intracranial pressure monitoring, expansion of emergency stroke and trauma care, enhanced focus on rapid diagnosis and intervention.
The rising cases of brain disorders are expected to propel the growth of the intracranial hemorrhage devices market going forward. Brain disorders refer to a wide range of conditions that affect the structure, function, or chemistry of the brain, leading to disruptions in normal brain processes. The cases of brain disorders are increasing due to factors such as improved diagnostics, aging populations, lifestyle changes, and greater awareness, along with rising stress. Intracranial hemorrhage devices are used to detect, monitor, and treat brain disorders involving bleeding by identifying hemorrhages, managing pressure, and removing blood clots to prevent further brain damage. For instance, in October 2025, according to the World Health Organization, a Switzerland-based Intergovernmental organization reported that The WHO warns that fewer than one in three countries have a national policy to tackle neurological disorders, which cause over 11 million deaths annually. Additionally, its new report shows these conditions affect over 3 billion people,more than 40% of the global population. Therefore, the rising cases of brain disorders drive the growth of the intracranial hemorrhage devices market.
Leading companies in the intracranial hemorrhage devices market are focused on creating innovative products, such as advanced neuro access devices, to improve the precision and efficiency of diagnosing and treating brain injuries. These devices are specialized tools and technologies designed to provide accurate access to the brain or nervous system for diagnostic, surgical, or therapeutic purposes. For instance, in June 2024, Penumbra Inc., a medical device company based in the US, launched its advanced neuro access devices, BMX81 and BMX96, in Europe. These devices, designed for managing ischemic and hemorrhagic strokes, use advanced laser-cut stainless steel hypotube technology to enhance stability and trackability while allowing for larger inner diameters. This launch underscores Penumbra's dedication to improving stroke care in Europe.
In September 2024, Stryker Corporation, a US-based medical company, acquired NICO Corporation for an undisclosed amount. The acquisition aims to strengthen Stryker’s neurotechnology capabilities in tumor and stroke care, as well as expand its portfolio of solutions for tumor resection and the treatment of intracerebral hemorrhage. NICO Corporation, a US-based medical equipment manufacturer, specializes in devices for treating intracranial hemorrhage (ICH).
Major companies operating in the intracranial hemorrhage devices market are Johnson & Johnson Services Inc., Medtronic Inc., Siemens Healthcare GmbH, Stryker Corporation, General Electric Company, Terumo Corporation, Canon Medical Systems Corporation, Penumbra Inc., MicroPort Scientific Corporation, Aidoc Medical Ltd., Viz.ai Inc., Phenox GmbH, RAPID AI Inc., Acandis GmbH, Kaneka Medix Corporation, Hyperfine Inc., ClearMind Biomedical Inc., InfraScan Inc., Schindler Endoskopie Technologie GmbH, Sense Neuro Diagnostics Inc., MaxQ AI Inc., Invamed Inc.
North America was the largest region in the intracranial hemorrhage devices market in 2025. The regions covered in the intracranial hemorrhage devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intracranial hemorrhage devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intracranial hemorrhage devices market by increasing costs of imported imaging systems, monitoring sensors, surgical instruments, and electronic components used in diagnostic and treatment devices. Hospitals in North America and Europe are most affected due to reliance on advanced imported imaging and monitoring equipment, while Asia-Pacific faces higher capital expenditure for device procurement. These tariffs are raising treatment costs and delaying equipment upgrades. However, they are also encouraging domestic manufacturing, localized assembly, and investment in regional neurodevice development capabilities.
The intracranial hemorrhage devices market research report is one of a series of new reports that provides intracranial hemorrhage devices market statistics, including intracranial hemorrhage devices industry global market size, regional shares, competitors with a intracranial hemorrhage devices market share, detailed intracranial hemorrhage devices market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial hemorrhage devices industry. This intracranial hemorrhage devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intracranial hemorrhage devices are medical tools designed for diagnosing, managing, and treating intracranial hemorrhages (ICH), which are bleeding events within the skull. These devices are essential for addressing conditions such as subdural hematoma, epidural hematoma, subarachnoid hemorrhage, and intracerebral hemorrhage.
The primary product categories for intracranial hemorrhage devices include diagnostic and treatment devices. Intracranial hemorrhage diagnosis refers to the process of detecting bleeding within the skull, utilizing both invasive and non-invasive devices. These devices serve various end users, such as hospitals, ambulatory surgical centers, and other healthcare facilities.
The intracranial hemorrhage devices market consists of sales of embolization devices, computed tomography scanners, balloon occlusion devices, and neuro-thrombectomy devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Intracranial Hemorrhage Devices Market Characteristics
3. Intracranial Hemorrhage Devices Market Supply Chain Analysis
4. Global Intracranial Hemorrhage Devices Market Trends and Strategies
5. Intracranial Hemorrhage Devices Market Analysis of End Use Industries
7. Global Intracranial Hemorrhage Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Intracranial Hemorrhage Devices Total Addressable Market (TAM) Analysis for the Market
9. Intracranial Hemorrhage Devices Market Segmentation
10. Intracranial Hemorrhage Devices Market Regional and Country Analysis
11. Asia-Pacific Intracranial Hemorrhage Devices Market
12. China Intracranial Hemorrhage Devices Market
13. India Intracranial Hemorrhage Devices Market
14. Japan Intracranial Hemorrhage Devices Market
15. Australia Intracranial Hemorrhage Devices Market
16. Indonesia Intracranial Hemorrhage Devices Market
17. South Korea Intracranial Hemorrhage Devices Market
18. Taiwan Intracranial Hemorrhage Devices Market
19. South East Asia Intracranial Hemorrhage Devices Market
20. Western Europe Intracranial Hemorrhage Devices Market
21. UK Intracranial Hemorrhage Devices Market
22. Germany Intracranial Hemorrhage Devices Market
23. France Intracranial Hemorrhage Devices Market
24. Italy Intracranial Hemorrhage Devices Market
25. Spain Intracranial Hemorrhage Devices Market
26. Eastern Europe Intracranial Hemorrhage Devices Market
27. Russia Intracranial Hemorrhage Devices Market
28. North America Intracranial Hemorrhage Devices Market
29. USA Intracranial Hemorrhage Devices Market
30. Canada Intracranial Hemorrhage Devices Market
31. South America Intracranial Hemorrhage Devices Market
32. Brazil Intracranial Hemorrhage Devices Market
33. Middle East Intracranial Hemorrhage Devices Market
34. Africa Intracranial Hemorrhage Devices Market
36. Intracranial Hemorrhage Devices Market Competitive Landscape and Company Profiles
37. Intracranial Hemorrhage Devices Market Other Major and Innovative Companies
40. Intracranial Hemorrhage Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Intracranial Hemorrhage Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses intracranial hemorrhage devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intracranial hemorrhage devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intracranial hemorrhage devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Diagnosis; Treatment2) By Devices: Invasive; Non-Invasive
3) By End Users: Hospitals; Ambulatory Surgical Centres; Other End Users
Subsegments:
1) By Diagnosis: MRI (Magnetic Resonance Imaging) Devices; CT (Computed Tomography) Scanners; Ultrasound Devices; EEG (Electroencephalogram) Devices; Intracranial Pressure Monitors; Blood Gas Analyzers2) By Treatment: Surgical Instruments (Craniotomy Instruments); Drainage Devices (Ventriculostomy Catheters); Embolization Devices; Hemostatic Agents; Coagulation Devices; Neurostimulation Devices
Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic Inc.; Siemens Healthcare GmbH; Stryker Corporation; General Electric Company; Terumo Corporation; Canon Medical Systems Corporation; Penumbra Inc.; MicroPort Scientific Corporation; Aidoc Medical Ltd.; Viz.ai Inc.; Phenox GmbH; RAPID AI Inc.; Acandis GmbH; Kaneka Medix Corporation; Hyperfine Inc.; ClearMind Biomedical Inc.; InfraScan Inc.; Schindler Endoskopie Technologie GmbH; Sense Neuro Diagnostics Inc.; MaxQ AI Inc.; Invamed Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Intracranial Hemorrhage Devices market report include:- Johnson & Johnson Services Inc.
- Medtronic Inc.
- Siemens Healthcare GmbH
- Stryker Corporation
- General Electric Company
- Terumo Corporation
- Canon Medical Systems Corporation
- Penumbra Inc.
- MicroPort Scientific Corporation
- Aidoc Medical Ltd.
- Viz.ai Inc.
- Phenox GmbH
- RAPID AI Inc.
- Acandis GmbH
- Kaneka Medix Corporation
- Hyperfine Inc.
- ClearMind Biomedical Inc.
- InfraScan Inc.
- Schindler Endoskopie Technologie GmbH
- Sense Neuro Diagnostics Inc.
- MaxQ AI Inc.
- Invamed Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.88 Billion |
| Forecasted Market Value ( USD | $ 2.27 Billion |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
